Literature DB >> 10749588

A comparative survival evaluation and assessment of interclassification concordance in adult supratentorial astrocytic tumors.

A K Karak1, R Singh, P N Tandon, C Sarkar.   

Abstract

Classification and grading of astrocytic tumors has been the subject of several controversies and no universally accepted classification system is yet available. Nevertheless, acceptance of a common system is important for assessing prognosis as well as easy comparative evaluation and interpretation of the results of multi-center therapeutic trials. We report the results of a single center study on comparative survival evaluation along with assessment of inter-classification concordance in 102 cases of supratentorial astrocytic tumors in adults ((3) (3)16 years of age). Hematoxylin and eosin (H&E) stained slides of these 102 cases were reviewed independently by two pathologists and each case classified or graded according to four different classification systems viz. Kernohan, Daumas-Duport (SAM-A), TESTAST-268 and WHO. The histological grading was then correlated with the survival curves as estimated by the Kaplan-Meier method. The most important observation was that similar survival curves were obtained for any one grade of tumor by all the four classification systems. Fifty three of the 102 cases (51.9%) showed absolute grading concordance using all 4 classifications with maximum concordant cases belonging to grades 2 and 4. Intra-classification grade-wise survival analysis revealed a statistically significant difference between grade 2 and grades 3 or 4, but no difference between grades 3 and 4 in any of the classification systems. It is apparent from the results of this study that if specified criteria related to any of the classification systems is rigorously adhered to, it will produce comparable results. Hence, preferential adoption of any one classification system in practice will be guided by the relative ease of histologic feature value evaluation with maximum possible objectivity and reproducibility. We recommend the Daumas-Duport (SAM-A) system since it appears to be the simplest, most objectivized for practical application and highly reproducible with relative ease.

Entities:  

Mesh:

Year:  2000        PMID: 10749588     DOI: 10.1007/bf03032658

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  14 in total

1.  Computer-aided classification of malignancy in astrocytomas. II. The value of categorically evaluated histologic and non-histologic features for a numerical classifier.

Authors:  H P Schmitt; C Oberwittler
Journal:  Anal Cell Pathol       Date:  1992-11       Impact factor: 2.916

2.  Computer-aided classification of malignancy in astrocytomas. I. The value of nuclear parameters obtained by automated black and white image analysis.

Authors:  H P Schmitt; C Oberwittler; L R Schad
Journal:  Anal Cell Pathol       Date:  1992-11       Impact factor: 2.916

3.  Grading of gliomas.

Authors:  N RINGERTZ
Journal:  Acta Pathol Microbiol Scand       Date:  1950

4.  A grading study of gliomas using computer aided malignancy classification and histologic morphometry.

Authors:  S Sharma; A K Karak; C Sarkar; G Gomathy; A K Banerji; H P Schmitt
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

5.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

6.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

7.  Correlates of survival and the Daumas-Duport grading system for astrocytomas.

Authors:  T S Kim; A L Halliday; E T Hedley-Whyte; K Convery
Journal:  J Neurosurg       Date:  1991-01       Impact factor: 5.115

8.  Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.

Authors:  P C Burger; F S Vogel; S B Green; T A Strike
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

9.  Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

Authors:  D F Nelson; J S Nelson; D R Davis; C H Chang; T W Griffin; T F Pajak
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

10.  The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum.

Authors:  D M Garcia; K H Fulling; J E Marks
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

View more
  3 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.

Authors:  Margaret Wrensch; Terri Rice; Rei Miike; Alex McMillan; Kathleen R Lamborn; Kenneth Aldape; Michael D Prados
Journal:  Neuro Oncol       Date:  2006-01       Impact factor: 12.300

3.  RNAi-mediated knockdown of E2F2 inhibits tumorigenicity of human glioblastoma cells.

Authors:  Adriana M Nakahata; Daniela E Suzuki; Carolina O Rodini; Mayara L Fiuza; Oswaldo K Okamoto
Journal:  Oncol Lett       Date:  2014-07-22       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.